
Pharvaris
Data breach claim reported November 17, 2026
| Data Breach Report | |||
|---|---|---|---|
| Victim | pharvaris.com | ||
| Claimed By | n0n | ||
| Date Discovered | Nov 17, 2026 | ||
| Description | Pharvaris is a late-stage biopharmaceutical company based in the Netherlands, developing oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema attacks. | ||
| Leak Size | Unknown |
Breach claims on this page are published by threat actors and haven't been verified by Breachsense.
Credential Exposure for pharvaris.com
We've indexed 2 @pharvaris.com accounts from external breaches.
Last checked Nov 17, 2026
| @pharvaris.com addresses from external breaches | |
|---|---|
| Third-party breaches | 1 accounts · across 1 breaches · most recent Nov 15, 2020 |
| Combo lists | 1 accounts · most recent Oct 27, 2025 |
None of this is necessarily connected to the ransomware attack above.
Is your organization next?
Check if your company's credentials have been exposed in this or other data breaches.
Continuous dark web monitoring alerts you when we find leaked credentials or session tokens for your company.